GlassScriptPhysician profile
Ijaz Ahmed
NPI 1346988037
$2,901.69
in general payments reported to CMS, 2019-2025
15 companies · $1,020 in 2025
The $1,020 reported for 2025 was more than what 88% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $30.83 · 2023: $985 · 2024: $866 · 2025: $1,020.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,784 · Education: $86.66.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,784.20 |
| Education | $86.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $534.81 | 2023-2024 | Airsupra, Breztri, Tagrisso |
| Regeneron Healthcare Solutions, INC. | $521.87 | 2023-2025 | Dupixent |
| Genzyme Corporation | $400.42 | 2023-2025 | |
| Insmed, INC. | $352.46 | 2023-2025 | Arikayce |
| Actelion Pharmaceuticals US, INC. | $236.13 | 2025 | Opsumit, Uptravi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $216.09 | 2022-2024 | |
| Mylan Specialty L.P. | $200.77 | 2024 | Yupelri |
| Viatris Specialty LLC | $166.98 | 2025 | Yupelri |
| Pulmonx Corporation | $84.00 | 2024 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Chartis Catheter |
| Philips North America LLC | $61.93 | 2023-2024 | (Di7) Home Pi Undivided |
| Takeda Pharmaceuticals U.S.A., INC. | $32.05 | 2023 | Glassia |
| Genentech USA, INC. | $25.16 | 2023 | Xolair |
| United Therapeutics Corporation | $24.95 | 2025 | Tyvaso |
| Amgen INC. | $24.45 | 2024 | Tezspire |
| Harmony Biosciences LLC | $19.62 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ijaz Ahmed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.